Clinical Trials for Infectious Disease and Vaccines
Clinical Trials for Infectious Disease and Vaccines
The need for innovative treatments and vaccines for infectious diseases pushes clinical trial sponsors to operate faster across broader geographies within tighter regulatory demands. Yet for many global studies, it’s not scientific hurdles that slow progress — it’s operational fragmentation and a lack of global harmonization.
Every time a trial relies on separate labs in the U.S., Europe or Africa, the risk grows. Data becomes siloed, laboratory methods drift and timelines stretch as teams struggle to reconcile results.
MLM Medical Labs offers a unified, global approach. By connecting our U.S. and European central labs directly with our fully CAP-accredited central laboratory based in South Africa, sponsors gain a strategic and agile partner across every stage of their trial, from sample collection to data delivery.
Central Laboratory Services for Global Infectious Disease Studies
Whether managing infectious disease clinical trials or a regional epidemiology study, you shouldn’t have to choose between speed and standards. As a single-source partner, MLM Medical Labs ensures uniformity with a seamlessly harmonized laboratory network for consistent oversight regardless of regional complexities.
This integrated model supports:
- Prophylactic vaccine trials: Phase I–III efficacy and immunogenicity studies across diverse patient populations.
- Therapeutic trials: Comprehensive support for new antiviral, antibacterial and antifungal agents.
- Epidemiology and surveillance: High-volume seroprevalence and surveillance studies.
Advanced Immunogenicity and Vaccine Development Assay
MLM Medical Labs delivers specialized assay platforms and logistical expertise to generate consistent, high-quality data throughout various phases of vaccine and therapeutic development.
PBMC Isolation and Cryopreservation
High-integrity Peripheral Blood Mononuclear Cell (PBMC) samples are foundational for immune monitoring in infectious disease clinical trials. MLM Medical Labs employs rapid stabilization protocols and controlled logistics to ensure >90% PBMC viability, supporting Enzyme-Linked ImmunoSpot (ELISpot), flow cytometry and cellular sequencing studies across a range of geographies — even for multisite vaccine and therapeutic programs.
Harmonized Flow Cytometry
Each of our global labs is equipped with harmonized instrumentation and validated protocols for multiparametric flow cytometry. Our services include immunophenotyping of CD4/CD8 T-cell subsets, intracellular cytokine staining and receptor occupancy assays to inform dose selection.
Serology
Precise antibody profiling is essential for vaccine efficacy studies and for tracking immune response in HIV clinical trials. MLM Medical Labs uses validated, high-throughput ELISA and multiplex immunoassays to measure neutralizing antibody titers and seroconversion rates.
Biomarker Validation
MLM Medical Labs supports a full biomarker validation process, from assay development and qualification to regulatory-compliant validation. We enable sponsors to include novel or exploratory endpoints in infectious disease and vaccine studies, ensuring all biomarker data is reproducible and submission-ready.
Our Molecular Diagnostics and Pathogen-Specific Capabilities
MLM Medical Labs provides advanced molecular diagnostics and pathogen-specific testing to support real-time data for rapid decision-making. Our capabilities include:
- High-containment pathogens: Biosafety Level 3 (BSL-3) containment enables secure handling of high-containment infectious agents such as MDR- and XDR-TB, with support for rapid molecular detection, resistance prediction, culture and PCR.
- Viral load monitoring: Precise quantification and genotyping for HIV-1/2, HBV and HCV, as well as multiplex PCR panels for respiratory viruses and outbreak response.
- Rapid molecular testing: Automated, high-throughput PCR platforms ensure fast sample-to-result turnaround for enrollment and scalable throughput for both focused studies and large phase III protocols.
Why Trust Us for Infectious Disease and Vaccine Clinical Trials?
MLM Medical Labs delivers a seamless, global laboratory partnership for infectious disease studies that combines operational efficiency, rigorous quality control and scientific expertise from first patient to database lock.
Choosing us provides your organization with proven advantages, including:
- Faster study startup with in-region kit production, logistics and regulatory expertise.
- Expert PhD-led teams for scientific oversight and tailored assay development at every phase.
- Direct access to diverse patient populations.
- Single-source lab integration with harmonized systems spanning the U.S., Europe and Africa.
- Real-time sample tracking and results access through the mlm online® portal.
- Secure, audit-ready biostorage and validated cold-chain logistics for sensitive analytes.
Get Ready to Power Next-Generation Vaccines
Streamline and accelerate your infectious disease studies worldwide. The experienced team at MLM Medical Labs can support you from study design through data delivery, improving consistent quality and operational excellence across every region.
Request your proposal to learn more.